Drug General Information
Drug ID
D0G3AR
Former ID
DIB004587
Drug Name
CX-717
Synonyms
CX-1763; CX-546; CX-614; CX-727; CX-729; CX-743; CX-815; S-40929; AMPAKINE compound (respiratory depression), BiovailLaboratories; AMPAKINE compound (respiratory depression), Valeant; First generation AMPA receptor modulators, Cortex/University of California; First-generation AMPAKINE compounds, University of California/Cortex
Drug Type
Small molecular drug
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Preclinical [542783], [547144]
Company
University of California
Structure
Download
2D MOL

3D MOL

Formula
C13H13NO4
InChI
InChI=1S/C13H13NO4/c15-13-8-6-10-11(17-5-4-16-10)7-9(8)18-12-2-1-3-14(12)13/h6-7,12H,1-5H2
InChIKey
RQEPVMAYUINZRE-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Glutamate receptor AMPA subtype Target Info Modulator [531632]
References
Ref 542783(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7842).
Ref 547144Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013391)
Ref 531632Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep. J Psychopharmacol. 2012 Aug;26(8):1047-57.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.